We are live on
!
Find out more
1CM
1492 Capital Management Portfolio holdings
AUM
$263M
1-Year Est. Return
61.9%
This Fund
S&P 500
This Quarter
Est. Return
-18.23%
1 Year Est. Return
+61.9%
3 Year Est. Return
+187.15%
5 Year Est. Return
+242.53%
10 Year Est. Return
+2,731.07%
AUM
$112M
AUM Growth
-$42.1M
(-27%)
Cap. Flow
-$9.44M
Cap. Flow
% of AUM
-8.46%
Top 10 Holdings %
Top 10 Hldgs %
37.03%
Holding
115
New
23
Increased
16
Reduced
44
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Collegium Pharmaceutical
COLL
|
+$2.57M |
| 2 |
Kratos Defense & Security Solutions
KTOS
|
+$2.13M |
| 3 |
BDSI
BioDelivery Sciences International, Inc.
BDSI
|
+$1.97M |
| 4 |
OptimizeRx
OPRX
|
+$1.96M |
| 5 |
TherapeuticsMD
TXMD
|
+$1.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dycom Industries
DY
|
+$2.89M |
| 2 |
CPE
Callon Petroleum Company
CPE
|
+$2.88M |
| 3 |
CY
Cypress Semiconductor
CY
|
+$2.62M |
| 4 |
ATSG
Air Transport Services Group
ATSG
|
+$2.31M |
| 5 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$2.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.38% |
| 2 | Technology | 25.15% |
| 3 | Consumer Discretionary | 12.04% |
| 4 | Industrials | 6.25% |
| 5 | Financials | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
RingCentral
RNG
$4.05B
| $7.39M | 6.63% |
89,686
-3,497
| -4% | -$275K |
|
|
BEAT
2
DELISTED
BioTelemetry, Inc.
BEAT
| $4.85M | 4.34% |
81,151
-36,697
| -31% | -$2.2M |
|
|
WIFI
3
DELISTED
Boingo Wireless, Inc.
WIFI
| $4.52M | 4.05% |
219,791
-8,549
| -4% | -$228K |
|
|
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $4.17M | 3.74% |
213,360
+74,047
| +53% | +$1.45M |
|
5
LoveSac
LOVE
$239M
| $3.81M | 3.42% |
166,203
-3,336
| -2% | -$69.1K |
|
6
NeoGenomics
NEO
$1.81B
| $3.73M | 3.35% |
295,966
-63,329
| -18% | -$944K |
|
7
8x8 Inc
EGHT
$247M
| $3.71M | 3.32% |
205,361
+25,636
| +14% | +$471K |
|
|
BDSI
8
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $3.26M | 2.93% |
881,788
+561,265
| +175% | +$1.97M |
|
|
QADA
9
DELISTED
QAD Inc.
QADA
| $2.93M | 2.63% |
74,584
+15,630
| +27% | +$683K |
|
10
AMC Entertainment Holdings
AMC
$2.03B
| $2.93M | 2.62% |
23,837
-837
| -3% | -$137K |
|
11
Genesco
GCO
$396M
| $2.82M | 2.53% |
63,745
-19,989
| -24% | -$864K |
|
12
Lumentum
LITE
$59.4B
| $2.75M | 2.47% |
65,528
+19,072
| +41% | +$939K |
|
13
Seacoast Banking Corp of Florida
SBCF
$3.26B
| $2.73M | 2.45% |
104,803
-1,704
| -2% | -$45.6K |
|
|
14
TherapeuticsMD
TXMD
$23.8M
| $2.67M | 2.39% |
13,997
+6,636
| +90% | +$1.62M |
|
|
15
Collegium Pharmaceutical
COLL
$1.14B
| $2.58M | 2.31% |
+150,189
| New | +$2.57M |
|
|
TSC
16
DELISTED
TriState Capital Holdings, Inc.
TSC
| $2.35M | 2.1% |
120,613
-2,405
| -2% | -$58.4K |
|
|
FSB
17
DELISTED
Franklin Financial Network, Inc.
FSB
| $2.21M | 1.98% |
83,603
-2,537
| -3% | -$84K |
|
|
18
Kratos Defense & Security Solutions
KTOS
$8.88B
| $2.17M | 1.95% |
+154,271
| New | +$2.13M |
|
|
CSFL
19
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $2.02M | 1.81% |
96,172
-2,877
| -3% | -$69.7K |
|
20
Knight Transportation
KNX
$11.8B
| $1.8M | 1.62% |
71,973
-4,348
| -6% | -$135K |
|
|
PRMW
21
DELISTED
Primo Water Corporation
PRMW
| $1.71M | 1.54% |
122,306
-54,411
| -31% | -$833K |
|
22
QuinStreet
QNST
$870M
| $1.54M | 1.38% |
+95,136
| New | +$1.43M |
|
|
FNSR
23
DELISTED
Finisar Corp
FNSR
| $1.54M | 1.38% |
71,435
-4,416
| -6% | -$87.9K |
|
|
24
OptimizeRx
OPRX
$117M
| $1.45M | 1.3% |
+132,535
| New | +$1.96M |
|
25
Merit Medical Systems
MMSI
$4.43B
| $1.41M | 1.26% |
25,209
-1,841
| -7% | -$109K |
|
Similar funds
KA
LCGC
DEA
EAN
PIP
VIG
SC
L
1492 Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, 1492 Capital Management held 115 positions worth $112M, down 27% from $154M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
1492 Capital Management withdrew a net $9.44M in Q4 2018, closing 26 positions and reducing 44 holdings. Its most notable exit was Dycom Industries, an estimated $2.89M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, 1492 Capital Management opened a new position in Collegium Pharmaceutical worth $2.58M.
- 1492 Capital Management's largest Q4 2018 buy was Collegium Pharmaceutical: 150,189 shares worth $2.58M.
- 1492 Capital Management added most to BioDelivery Sciences International, Inc. in Q4 2018, an estimated $1.97M increase.
- 1492 Capital Management's biggest Q4 2018 reduction was BioTelemetry, Inc., cutting an estimated $2.2M.
- 1492 Capital Management fully exited Dycom Industries in Q4 2018, selling an estimated $2.89M.
- 1492 Capital Management's ten largest holdings make up 37% of its $112M portfolio in Q4 2018.
- 1492 Capital Management opened 23 new positions and closed 26 in Q4 2018.
- 1492 Capital Management's portfolio value fell 27% quarter-over-quarter to $112M.
Based on 1492 Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.